Crossmark

Novel antimicrobial peptide HFIAP-1 mutant as a β-lactamase inhibitor against extended-spectrum β-lactamases of Escherichia coli: a comprehensive in-silico approach

Crossref DOI link: https://doi.org/10.1007/s00203-025-04483-0

Published Online: 2025-09-24

Published Print: 2025-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

George, Elizabeth Annie https://orcid.org/0009-0005-7991-3447
Naha, Aniket https://orcid.org/0000-0002-6811-9767
Ramaiah, Sudha https://orcid.org/0000-0002-4800-329X
Funding

Funding for this research was provided by:

Indian Council of Medical Research (IRIS ID: 2021-11889)
License Information

Text and Data Mining valid from 2025-09-24

Version of Record valid from 2025-09-24
More Information

Article History

Received: 4 July 2025

Revised: 5 September 2025

Accepted: 10 September 2025

First Online: 24 September 2025

Declarations

:

: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Document is current

Any future updates will be listed below